Report Overview
Malaria Vaccines are used for malaria treatment. Malaria is a severe and widespread disease caused by a parasitic infection by protozoan Plasmodium when transmitted by various species of anopheles mosquitoes.
The global Malaria Vaccines market size was estimated at USD 1901 million in 2023 and is projected to reach USD 4519.27 million by 2032, exhibiting a CAGR of 10.10% during the forecast period.
North America Malaria Vaccines market size was estimated at USD 584.82 million in 2023, at a CAGR of 8.66% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Malaria Vaccines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Malaria Vaccines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Malaria Vaccines market in any manner.
Global Malaria Vaccines Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
GlaxoSmithKline Plc
Sanaria Inc
Nobelpharma Co
Sumaya Biotech
GenVec
Actiza Pharmaceutical Private Limited
AdvaCare Pharma
Ipca Laboratories Ltd
Bliss GVS Pharma Ltd
GeoVax
Pfizer Inc
VLP Therapeutics
OSIVAX
AJANTA PHARMA
Strides Pharma Science Limited
Mylan N.V.
Zydus Cadila
Cipla Inc
Sun Pharmaceutical Industries Ltd
Sanofi
Hikma Pharmaceuticals PLC
Amneal Pharmaceuticals LLC
Taj Pharmaceuticals Limited
Lupin
Novartis AG
CellFree Sciences
Market Segmentation (by Type)
Pre-Erythrocytic Vaccine
Erythrocytic Vaccine
Multi-antigen Vaccine
Market Segmentation (by Application)
Hospitals
Clinics
Community Centers
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Malaria Vaccines Market
Overview of the regional outlook of the Malaria Vaccines Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter�s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Malaria Vaccines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Malaria Vaccines, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Malaria Vaccines
1.2 Key Market Segments
1.2.1 Malaria Vaccines Segment by Type
1.2.2 Malaria Vaccines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Malaria Vaccines Market Overview
2.1 Global Market Overview
2.1.1 Global Malaria Vaccines Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Malaria Vaccines Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Malaria Vaccines Market Competitive Landscape
3.1 Global Malaria Vaccines Sales by Manufacturers (2019-2025)
3.2 Global Malaria Vaccines Revenue Market Share by Manufacturers (2019-2025)
3.3 Malaria Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Malaria Vaccines Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Malaria Vaccines Sales Sites, Area Served, Product Type
3.6 Malaria Vaccines Market Competitive Situation and Trends
3.6.1 Malaria Vaccines Market Concentration Rate
3.6.2 Global 5 and 10 Largest Malaria Vaccines Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Malaria Vaccines Industry Chain Analysis
4.1 Malaria Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Malaria Vaccines Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Malaria Vaccines Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Malaria Vaccines Sales Market Share by Type (2019-2025)
6.3 Global Malaria Vaccines Market Size Market Share by Type (2019-2025)
6.4 Global Malaria Vaccines Price by Type (2019-2025)
7 Malaria Vaccines Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Malaria Vaccines Market Sales by Application (2019-2025)
7.3 Global Malaria Vaccines Market Size (M USD) by Application (2019-2025)
7.4 Global Malaria Vaccines Sales Growth Rate by Application (2019-2025)
8 Malaria Vaccines Market Consumption by Region
8.1 Global Malaria Vaccines Sales by Region
8.1.1 Global Malaria Vaccines Sales by Region
8.1.2 Global Malaria Vaccines Sales Market Share by Region
8.2 North America
8.2.1 North America Malaria Vaccines Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Malaria Vaccines Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Malaria Vaccines Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Malaria Vaccines Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Malaria Vaccines Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Malaria Vaccines Market Production by Region
9.1 Global Production of Malaria Vaccines by Region (2019-2025)
9.2 Global Malaria Vaccines Revenue Market Share by Region (2019-2025)
9.3 Global Malaria Vaccines Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Malaria Vaccines Production
9.4.1 North America Malaria Vaccines Production Growth Rate (2019-2025)
9.4.2 North America Malaria Vaccines Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Malaria Vaccines Production
9.5.1 Europe Malaria Vaccines Production Growth Rate (2019-2025)
9.5.2 Europe Malaria Vaccines Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Malaria Vaccines Production (2019-2025)
9.6.1 Japan Malaria Vaccines Production Growth Rate (2019-2025)
9.6.2 Japan Malaria Vaccines Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Malaria Vaccines Production (2019-2025)
9.7.1 China Malaria Vaccines Production Growth Rate (2019-2025)
9.7.2 China Malaria Vaccines Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 GlaxoSmithKline Plc
10.1.1 GlaxoSmithKline Plc Malaria Vaccines Basic Information
10.1.2 GlaxoSmithKline Plc Malaria Vaccines Product Overview
10.1.3 GlaxoSmithKline Plc Malaria Vaccines Product Market Performance
10.1.4 GlaxoSmithKline Plc Business Overview
10.1.5 GlaxoSmithKline Plc Malaria Vaccines SWOT Analysis
10.1.6 GlaxoSmithKline Plc Recent Developments
10.2 Sanaria Inc
10.2.1 Sanaria Inc Malaria Vaccines Basic Information
10.2.2 Sanaria Inc Malaria Vaccines Product Overview
10.2.3 Sanaria Inc Malaria Vaccines Product Market Performance
10.2.4 Sanaria Inc Business Overview
10.2.5 Sanaria Inc Malaria Vaccines SWOT Analysis
10.2.6 Sanaria Inc Recent Developments
10.3 Nobelpharma Co
10.3.1 Nobelpharma Co Malaria Vaccines Basic Information
10.3.2 Nobelpharma Co Malaria Vaccines Product Overview
10.3.3 Nobelpharma Co Malaria Vaccines Product Market Performance
10.3.4 Nobelpharma Co Malaria Vaccines SWOT Analysis
10.3.5 Nobelpharma Co Business Overview
10.3.6 Nobelpharma Co Recent Developments
10.4 Sumaya Biotech
10.4.1 Sumaya Biotech Malaria Vaccines Basic Information
10.4.2 Sumaya Biotech Malaria Vaccines Product Overview
10.4.3 Sumaya Biotech Malaria Vaccines Product Market Performance
10.4.4 Sumaya Biotech Business Overview
10.4.5 Sumaya Biotech Recent Developments
10.5 GenVec
10.5.1 GenVec Malaria Vaccines Basic Information
10.5.2 GenVec Malaria Vaccines Product Overview
10.5.3 GenVec Malaria Vaccines Product Market Performance
10.5.4 GenVec Business Overview
10.5.5 GenVec Recent Developments
10.6 Actiza Pharmaceutical Private Limited
10.6.1 Actiza Pharmaceutical Private Limited Malaria Vaccines Basic Information
10.6.2 Actiza Pharmaceutical Private Limited Malaria Vaccines Product Overview
10.6.3 Actiza Pharmaceutical Private Limited Malaria Vaccines Product Market Performance
10.6.4 Actiza Pharmaceutical Private Limited Business Overview
10.6.5 Actiza Pharmaceutical Private Limited Recent Developments
10.7 AdvaCare Pharma
10.7.1 AdvaCare Pharma Malaria Vaccines Basic Information
10.7.2 AdvaCare Pharma Malaria Vaccines Product Overview
10.7.3 AdvaCare Pharma Malaria Vaccines Product Market Performance
10.7.4 AdvaCare Pharma Business Overview
10.7.5 AdvaCare Pharma Recent Developments
10.8 Ipca Laboratories Ltd
10.8.1 Ipca Laboratories Ltd Malaria Vaccines Basic Information
10.8.2 Ipca Laboratories Ltd Malaria Vaccines Product Overview
10.8.3 Ipca Laboratories Ltd Malaria Vaccines Product Market Performance
10.8.4 Ipca Laboratories Ltd Business Overview
10.8.5 Ipca Laboratories Ltd Recent Developments
10.9 Bliss GVS Pharma Ltd
10.9.1 Bliss GVS Pharma Ltd Malaria Vaccines Basic Information
10.9.2 Bliss GVS Pharma Ltd Malaria Vaccines Product Overview
10.9.3 Bliss GVS Pharma Ltd Malaria Vaccines Product Market Performance
10.9.4 Bliss GVS Pharma Ltd Business Overview
10.9.5 Bliss GVS Pharma Ltd Recent Developments
10.10 GeoVax
10.10.1 GeoVax Malaria Vaccines Basic Information
10.10.2 GeoVax Malaria Vaccines Product Overview
10.10.3 GeoVax Malaria Vaccines Product Market Performance
10.10.4 GeoVax Business Overview
10.10.5 GeoVax Recent Developments
10.11 Pfizer Inc
10.11.1 Pfizer Inc Malaria Vaccines Basic Information
10.11.2 Pfizer Inc Malaria Vaccines Product Overview
10.11.3 Pfizer Inc Malaria Vaccines Product Market Performance
10.11.4 Pfizer Inc Business Overview
10.11.5 Pfizer Inc Recent Developments
10.12 VLP Therapeutics
10.12.1 VLP Therapeutics Malaria Vaccines Basic Information
10.12.2 VLP Therapeutics Malaria Vaccines Product Overview
10.12.3 VLP Therapeutics Malaria Vaccines Product Market Performance
10.12.4 VLP Therapeutics Business Overview
10.12.5 VLP Therapeutics Recent Developments
10.13 OSIVAX
10.13.1 OSIVAX Malaria Vaccines Basic Information
10.13.2 OSIVAX Malaria Vaccines Product Overview
10.13.3 OSIVAX Malaria Vaccines Product Market Performance
10.13.4 OSIVAX Business Overview
10.13.5 OSIVAX Recent Developments
10.14 AJANTA PHARMA
10.14.1 AJANTA PHARMA Malaria Vaccines Basic Information
10.14.2 AJANTA PHARMA Malaria Vaccines Product Overview
10.14.3 AJANTA PHARMA Malaria Vaccines Product Market Performance
10.14.4 AJANTA PHARMA Business Overview
10.14.5 AJANTA PHARMA Recent Developments
10.15 Strides Pharma Science Limited
10.15.1 Strides Pharma Science Limited Malaria Vaccines Basic Information
10.15.2 Strides Pharma Science Limited Malaria Vaccines Product Overview
10.15.3 Strides Pharma Science Limited Malaria Vaccines Product Market Performance
10.15.4 Strides Pharma Science Limited Business Overview
10.15.5 Strides Pharma Science Limited Recent Developments
10.16 Mylan N.V.
10.16.1 Mylan N.V. Malaria Vaccines Basic Information
10.16.2 Mylan N.V. Malaria Vaccines Product Overview
10.16.3 Mylan N.V. Malaria Vaccines Product Market Performance
10.16.4 Mylan N.V. Business Overview
10.16.5 Mylan N.V. Recent Developments
10.17 Zydus Cadila
10.17.1 Zydus Cadila Malaria Vaccines Basic Information
10.17.2 Zydus Cadila Malaria Vaccines Product Overview
10.17.3 Zydus Cadila Malaria Vaccines Product Market Performance
10.17.4 Zydus Cadila Business Overview
10.17.5 Zydus Cadila Recent Developments
10.18 Cipla Inc
10.18.1 Cipla Inc Malaria Vaccines Basic Information
10.18.2 Cipla Inc Malaria Vaccines Product Overview
10.18.3 Cipla Inc Malaria Vaccines Product Market Performance
10.18.4 Cipla Inc Business Overview
10.18.5 Cipla Inc Recent Developments
10.19 Sun Pharmaceutical Industries Ltd
10.19.1 Sun Pharmaceutical Industries Ltd Malaria Vaccines Basic Information
10.19.2 Sun Pharmaceutical Industries Ltd Malaria Vaccines Product Overview
10.19.3 Sun Pharmaceutical Industries Ltd Malaria Vaccines Product Market Performance
10.19.4 Sun Pharmaceutical Industries Ltd Business Overview
10.19.5 Sun Pharmaceutical Industries Ltd Recent Developments
10.20 Sanofi
10.20.1 Sanofi Malaria Vaccines Basic Information
10.20.2 Sanofi Malaria Vaccines Product Overview
10.20.3 Sanofi Malaria Vaccines Product Market Performance
10.20.4 Sanofi Business Overview
10.20.5 Sanofi Recent Developments
10.21 Hikma Pharmaceuticals PLC
10.21.1 Hikma Pharmaceuticals PLC Malaria Vaccines Basic Information
10.21.2 Hikma Pharmaceuticals PLC Malaria Vaccines Product Overview
10.21.3 Hikma Pharmaceuticals PLC Malaria Vaccines Product Market Performance
10.21.4 Hikma Pharmaceuticals PLC Business Overview
10.21.5 Hikma Pharmaceuticals PLC Recent Developments
10.22 Amneal Pharmaceuticals LLC
10.22.1 Amneal Pharmaceuticals LLC Malaria Vaccines Basic Information
10.22.2 Amneal Pharmaceuticals LLC Malaria Vaccines Product Overview
10.22.3 Amneal Pharmaceuticals LLC Malaria Vaccines Product Market Performance
10.22.4 Amneal Pharmaceuticals LLC Business Overview
10.22.5 Amneal Pharmaceuticals LLC Recent Developments
10.23 Taj Pharmaceuticals Limited
10.23.1 Taj Pharmaceuticals Limited Malaria Vaccines Basic Information
10.23.2 Taj Pharmaceuticals Limited Malaria Vaccines Product Overview
10.23.3 Taj Pharmaceuticals Limited Malaria Vaccines Product Market Performance
10.23.4 Taj Pharmaceuticals Limited Business Overview
10.23.5 Taj Pharmaceuticals Limited Recent Developments
10.24 Lupin
10.24.1 Lupin Malaria Vaccines Basic Information
10.24.2 Lupin Malaria Vaccines Product Overview
10.24.3 Lupin Malaria Vaccines Product Market Performance
10.24.4 Lupin Business Overview
10.24.5 Lupin Recent Developments
10.25 Novartis AG
10.25.1 Novartis AG Malaria Vaccines Basic Information
10.25.2 Novartis AG Malaria Vaccines Product Overview
10.25.3 Novartis AG Malaria Vaccines Product Market Performance
10.25.4 Novartis AG Business Overview
10.25.5 Novartis AG Recent Developments
10.26 CellFree Sciences
10.26.1 CellFree Sciences Malaria Vaccines Basic Information
10.26.2 CellFree Sciences Malaria Vaccines Product Overview
10.26.3 CellFree Sciences Malaria Vaccines Product Market Performance
10.26.4 CellFree Sciences Business Overview
10.26.5 CellFree Sciences Recent Developments
11 Malaria Vaccines Market Forecast by Region
11.1 Global Malaria Vaccines Market Size Forecast
11.2 Global Malaria Vaccines Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Malaria Vaccines Market Size Forecast by Country
11.2.3 Asia Pacific Malaria Vaccines Market Size Forecast by Region
11.2.4 South America Malaria Vaccines Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Malaria Vaccines by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Malaria Vaccines Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Malaria Vaccines by Type (2025-2032)
12.1.2 Global Malaria Vaccines Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Malaria Vaccines by Type (2025-2032)
12.2 Global Malaria Vaccines Market Forecast by Application (2025-2032)
12.2.1 Global Malaria Vaccines Sales (K MT) Forecast by Application
12.2.2 Global Malaria Vaccines Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Malaria Vaccines Market Size Comparison by Region (M USD)
Table 5. Global Malaria Vaccines Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Malaria Vaccines Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Malaria Vaccines Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Malaria Vaccines Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Malaria Vaccines as of 2022)
Table 10. Global Market Malaria Vaccines Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Malaria Vaccines Sales Sites and Area Served
Table 12. Manufacturers Malaria Vaccines Product Type
Table 13. Global Malaria Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Malaria Vaccines
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Malaria Vaccines Market Challenges
Table 22. Global Malaria Vaccines Sales by Type (K MT)
Table 23. Global Malaria Vaccines Market Size by Type (M USD)
Table 24. Global Malaria Vaccines Sales (K MT) by Type (2019-2025)
Table 25. Global Malaria Vaccines Sales Market Share by Type (2019-2025)
Table 26. Global Malaria Vaccines Market Size (M USD) by Type (2019-2025)
Table 27. Global Malaria Vaccines Market Size Share by Type (2019-2025)
Table 28. Global Malaria Vaccines Price (USD/MT) by Type (2019-2025)
Table 29. Global Malaria Vaccines Sales (K MT) by Application
Table 30. Global Malaria Vaccines Market Size by Application
Table 31. Global Malaria Vaccines Sales by Application (2019-2025) & (K MT)
Table 32. Global Malaria Vaccines Sales Market Share by Application (2019-2025)
Table 33. Global Malaria Vaccines Sales by Application (2019-2025) & (M USD)
Table 34. Global Malaria Vaccines Market Share by Application (2019-2025)
Table 35. Global Malaria Vaccines Sales Growth Rate by Application (2019-2025)
Table 36. Global Malaria Vaccines Sales by Region (2019-2025) & (K MT)
Table 37. Global Malaria Vaccines Sales Market Share by Region (2019-2025)
Table 38. North America Malaria Vaccines Sales by Country (2019-2025) & (K MT)
Table 39. Europe Malaria Vaccines Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Malaria Vaccines Sales by Region (2019-2025) & (K MT)
Table 41. South America Malaria Vaccines Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Malaria Vaccines Sales by Region (2019-2025) & (K MT)
Table 43. Global Malaria Vaccines Production (K MT) by Region (2019-2025)
Table 44. Global Malaria Vaccines Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Malaria Vaccines Revenue Market Share by Region (2019-2025)
Table 46. Global Malaria Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Malaria Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Malaria Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Malaria Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Malaria Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. GlaxoSmithKline Plc Malaria Vaccines Basic Information
Table 52. GlaxoSmithKline Plc Malaria Vaccines Product Overview
Table 53. GlaxoSmithKline Plc Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. GlaxoSmithKline Plc Business Overview
Table 55. GlaxoSmithKline Plc Malaria Vaccines SWOT Analysis
Table 56. GlaxoSmithKline Plc Recent Developments
Table 57. Sanaria Inc Malaria Vaccines Basic Information
Table 58. Sanaria Inc Malaria Vaccines Product Overview
Table 59. Sanaria Inc Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. Sanaria Inc Business Overview
Table 61. Sanaria Inc Malaria Vaccines SWOT Analysis
Table 62. Sanaria Inc Recent Developments
Table 63. Nobelpharma Co Malaria Vaccines Basic Information
Table 64. Nobelpharma Co Malaria Vaccines Product Overview
Table 65. Nobelpharma Co Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. Nobelpharma Co Malaria Vaccines SWOT Analysis
Table 67. Nobelpharma Co Business Overview
Table 68. Nobelpharma Co Recent Developments
Table 69. Sumaya Biotech Malaria Vaccines Basic Information
Table 70. Sumaya Biotech Malaria Vaccines Product Overview
Table 71. Sumaya Biotech Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. Sumaya Biotech Business Overview
Table 73. Sumaya Biotech Recent Developments
Table 74. GenVec Malaria Vaccines Basic Information
Table 75. GenVec Malaria Vaccines Product Overview
Table 76. GenVec Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. GenVec Business Overview
Table 78. GenVec Recent Developments
Table 79. Actiza Pharmaceutical Private Limited Malaria Vaccines Basic Information
Table 80. Actiza Pharmaceutical Private Limited Malaria Vaccines Product Overview
Table 81. Actiza Pharmaceutical Private Limited Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. Actiza Pharmaceutical Private Limited Business Overview
Table 83. Actiza Pharmaceutical Private Limited Recent Developments
Table 84. AdvaCare Pharma Malaria Vaccines Basic Information
Table 85. AdvaCare Pharma Malaria Vaccines Product Overview
Table 86. AdvaCare Pharma Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. AdvaCare Pharma Business Overview
Table 88. AdvaCare Pharma Recent Developments
Table 89. Ipca Laboratories Ltd Malaria Vaccines Basic Information
Table 90. Ipca Laboratories Ltd Malaria Vaccines Product Overview
Table 91. Ipca Laboratories Ltd Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 92. Ipca Laboratories Ltd Business Overview
Table 93. Ipca Laboratories Ltd Recent Developments
Table 94. Bliss GVS Pharma Ltd Malaria Vaccines Basic Information
Table 95. Bliss GVS Pharma Ltd Malaria Vaccines Product Overview
Table 96. Bliss GVS Pharma Ltd Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 97. Bliss GVS Pharma Ltd Business Overview
Table 98. Bliss GVS Pharma Ltd Recent Developments
Table 99. GeoVax Malaria Vaccines Basic Information
Table 100. GeoVax Malaria Vaccines Product Overview
Table 101. GeoVax Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 102. GeoVax Business Overview
Table 103. GeoVax Recent Developments
Table 104. Pfizer Inc Malaria Vaccines Basic Information
Table 105. Pfizer Inc Malaria Vaccines Product Overview
Table 106. Pfizer Inc Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 107. Pfizer Inc Business Overview
Table 108. Pfizer Inc Recent Developments
Table 109. VLP Therapeutics Malaria Vaccines Basic Information
Table 110. VLP Therapeutics Malaria Vaccines Product Overview
Table 111. VLP Therapeutics Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 112. VLP Therapeutics Business Overview
Table 113. VLP Therapeutics Recent Developments
Table 114. OSIVAX Malaria Vaccines Basic Information
Table 115. OSIVAX Malaria Vaccines Product Overview
Table 116. OSIVAX Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 117. OSIVAX Business Overview
Table 118. OSIVAX Recent Developments
Table 119. AJANTA PHARMA Malaria Vaccines Basic Information
Table 120. AJANTA PHARMA Malaria Vaccines Product Overview
Table 121. AJANTA PHARMA Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 122. AJANTA PHARMA Business Overview
Table 123. AJANTA PHARMA Recent Developments
Table 124. Strides Pharma Science Limited Malaria Vaccines Basic Information
Table 125. Strides Pharma Science Limited Malaria Vaccines Product Overview
Table 126. Strides Pharma Science Limited Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 127. Strides Pharma Science Limited Business Overview
Table 128. Strides Pharma Science Limited Recent Developments
Table 129. Mylan N.V. Malaria Vaccines Basic Information
Table 130. Mylan N.V. Malaria Vaccines Product Overview
Table 131. Mylan N.V. Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 132. Mylan N.V. Business Overview
Table 133. Mylan N.V. Recent Developments
Table 134. Zydus Cadila Malaria Vaccines Basic Information
Table 135. Zydus Cadila Malaria Vaccines Product Overview
Table 136. Zydus Cadila Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 137. Zydus Cadila Business Overview
Table 138. Zydus Cadila Recent Developments
Table 139. Cipla Inc Malaria Vaccines Basic Information
Table 140. Cipla Inc Malaria Vaccines Product Overview
Table 141. Cipla Inc Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 142. Cipla Inc Business Overview
Table 143. Cipla Inc Recent Developments
Table 144. Sun Pharmaceutical Industries Ltd Malaria Vaccines Basic Information
Table 145. Sun Pharmaceutical Industries Ltd Malaria Vaccines Product Overview
Table 146. Sun Pharmaceutical Industries Ltd Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 147. Sun Pharmaceutical Industries Ltd Business Overview
Table 148. Sun Pharmaceutical Industries Ltd Recent Developments
Table 149. Sanofi Malaria Vaccines Basic Information
Table 150. Sanofi Malaria Vaccines Product Overview
Table 151. Sanofi Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 152. Sanofi Business Overview
Table 153. Sanofi Recent Developments
Table 154. Hikma Pharmaceuticals PLC Malaria Vaccines Basic Information
Table 155. Hikma Pharmaceuticals PLC Malaria Vaccines Product Overview
Table 156. Hikma Pharmaceuticals PLC Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 157. Hikma Pharmaceuticals PLC Business Overview
Table 158. Hikma Pharmaceuticals PLC Recent Developments
Table 159. Amneal Pharmaceuticals LLC Malaria Vaccines Basic Information
Table 160. Amneal Pharmaceuticals LLC Malaria Vaccines Product Overview
Table 161. Amneal Pharmaceuticals LLC Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 162. Amneal Pharmaceuticals LLC Business Overview
Table 163. Amneal Pharmaceuticals LLC Recent Developments
Table 164. Taj Pharmaceuticals Limited Malaria Vaccines Basic Information
Table 165. Taj Pharmaceuticals Limited Malaria Vaccines Product Overview
Table 166. Taj Pharmaceuticals Limited Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 167. Taj Pharmaceuticals Limited Business Overview
Table 168. Taj Pharmaceuticals Limited Recent Developments
Table 169. Lupin Malaria Vaccines Basic Information
Table 170. Lupin Malaria Vaccines Product Overview
Table 171. Lupin Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 172. Lupin Business Overview
Table 173. Lupin Recent Developments
Table 174. Novartis AG Malaria Vaccines Basic Information
Table 175. Novartis AG Malaria Vaccines Product Overview
Table 176. Novartis AG Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 177. Novartis AG Business Overview
Table 178. Novartis AG Recent Developments
Table 179. CellFree Sciences Malaria Vaccines Basic Information
Table 180. CellFree Sciences Malaria Vaccines Product Overview
Table 181. CellFree Sciences Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 182. CellFree Sciences Business Overview
Table 183. CellFree Sciences Recent Developments
Table 184. Global Malaria Vaccines Sales Forecast by Region (2025-2032) & (K MT)
Table 185. Global Malaria Vaccines Market Size Forecast by Region (2025-2032) & (M USD)
Table 186. North America Malaria Vaccines Sales Forecast by Country (2025-2032) & (K MT)
Table 187. North America Malaria Vaccines Market Size Forecast by Country (2025-2032) & (M USD)
Table 188. Europe Malaria Vaccines Sales Forecast by Country (2025-2032) & (K MT)
Table 189. Europe Malaria Vaccines Market Size Forecast by Country (2025-2032) & (M USD)
Table 190. Asia Pacific Malaria Vaccines Sales Forecast by Region (2025-2032) & (K MT)
Table 191. Asia Pacific Malaria Vaccines Market Size Forecast by Region (2025-2032) & (M USD)
Table 192. South America Malaria Vaccines Sales Forecast by Country (2025-2032) & (K MT)
Table 193. South America Malaria Vaccines Market Size Forecast by Country (2025-2032) & (M USD)
Table 194. Middle East and Africa Malaria Vaccines Consumption Forecast by Country (2025-2032) & (Units)
Table 195. Middle East and Africa Malaria Vaccines Market Size Forecast by Country (2025-2032) & (M USD)
Table 196. Global Malaria Vaccines Sales Forecast by Type (2025-2032) & (K MT)
Table 197. Global Malaria Vaccines Market Size Forecast by Type (2025-2032) & (M USD)
Table 198. Global Malaria Vaccines Price Forecast by Type (2025-2032) & (USD/MT)
Table 199. Global Malaria Vaccines Sales (K MT) Forecast by Application (2025-2032)
Table 200. Global Malaria Vaccines Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Malaria Vaccines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Malaria Vaccines Market Size (M USD), 2019-2032
Figure 5. Global Malaria Vaccines Market Size (M USD) (2019-2032)
Figure 6. Global Malaria Vaccines Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Malaria Vaccines Market Size by Country (M USD)
Figure 11. Malaria Vaccines Sales Share by Manufacturers in 2023
Figure 12. Global Malaria Vaccines Revenue Share by Manufacturers in 2023
Figure 13. Malaria Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Malaria Vaccines Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Malaria Vaccines Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Malaria Vaccines Market Share by Type
Figure 18. Sales Market Share of Malaria Vaccines by Type (2019-2025)
Figure 19. Sales Market Share of Malaria Vaccines by Type in 2023
Figure 20. Market Size Share of Malaria Vaccines by Type (2019-2025)
Figure 21. Market Size Market Share of Malaria Vaccines by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Malaria Vaccines Market Share by Application
Figure 24. Global Malaria Vaccines Sales Market Share by Application (2019-2025)
Figure 25. Global Malaria Vaccines Sales Market Share by Application in 2023
Figure 26. Global Malaria Vaccines Market Share by Application (2019-2025)
Figure 27. Global Malaria Vaccines Market Share by Application in 2023
Figure 28. Global Malaria Vaccines Sales Growth Rate by Application (2019-2025)
Figure 29. Global Malaria Vaccines Sales Market Share by Region (2019-2025)
Figure 30. North America Malaria Vaccines Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Malaria Vaccines Sales Market Share by Country in 2023
Figure 32. U.S. Malaria Vaccines Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Malaria Vaccines Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Malaria Vaccines Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Malaria Vaccines Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Malaria Vaccines Sales Market Share by Country in 2023
Figure 37. Germany Malaria Vaccines Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Malaria Vaccines Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Malaria Vaccines Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Malaria Vaccines Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Malaria Vaccines Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Malaria Vaccines Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Malaria Vaccines Sales Market Share by Region in 2023
Figure 44. China Malaria Vaccines Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Malaria Vaccines Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Malaria Vaccines Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Malaria Vaccines Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Malaria Vaccines Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Malaria Vaccines Sales and Growth Rate (K MT)
Figure 50. South America Malaria Vaccines Sales Market Share by Country in 2023
Figure 51. Brazil Malaria Vaccines Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Malaria Vaccines Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Malaria Vaccines Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Malaria Vaccines Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Malaria Vaccines Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Malaria Vaccines Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Malaria Vaccines Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Malaria Vaccines Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Malaria Vaccines Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Malaria Vaccines Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Malaria Vaccines Production Market Share by Region (2019-2025)
Figure 62. North America Malaria Vaccines Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Malaria Vaccines Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Malaria Vaccines Production (K MT) Growth Rate (2019-2025)
Figure 65. China Malaria Vaccines Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Malaria Vaccines Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Malaria Vaccines Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Malaria Vaccines Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Malaria Vaccines Market Share Forecast by Type (2025-2032)
Figure 70. Global Malaria Vaccines Sales Forecast by Application (2025-2032)
Figure 71. Global Malaria Vaccines Market Share Forecast by Application (2025-2032)
